Although, regarded as an orphan receptor, recent findings suggest that LILRB3 interacts with ANGPTL2 and 5, complement components, and cytokeratin-associated proteins exposed on necrotic tumour cells and bacteria such as S. aureus (6, 23, 89, 92, 98, 146, 148). Here, LILRB3 is linked to neoplasm.